Keystone Symposia

Keystone Resort Floorplan

NOTES:
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


This meeting is part of the Global Health Series

Download Flyer
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Tuesday, June 6 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, June 10 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Sunday, June 11 in order to fully experience the meeting.

TUESDAY, JUNE 6

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


WEDNESDAY, JUNE 7

07:00—08:00
Breakfast

08:00—09:30
Welcome and Keynote Session (Joint)

Anthony S. Fauci†, , USA
Where Two Pandemics Meet: HIV and SARS-CoV-2

Rafi Ahmed, Emory University School of Medicine, USA
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers

Coffee Break

09:50—11:30
How B Cells Function in Infectious Diseases (Joint)

Shane Crotty, La Jolla Institute for Immunology, USA
Immune Memory to SARS-CoV-2 and COVID-19 Vaccines, and Lessons for HIV Vaccine Development

Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Refining the B Cell Repertoire by Somatic Hypermutation and Class Switch Recombination

Susan Moir, NIAID, National Institutes of Health, USA
B Cell Biology in Acute and Chronic Infectious Diseases

Short Talks Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop 1

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Control and Modulation of B Cell Responses

Frances E. Lund, University of Alabama at Birmingham, USA
Cytokine-Producing “Effector” B Cells

Darrell J. Irvine, Massachusetts Institute of Technology, USA
Controlled Modulation of B Cell Responses

Jenny Jiang, University of Pennsylvania, USA
A Systems Approach to Understanding B Cell Fates

Short Talks Chosen from Abstracts

17:00—19:00
Rational Vaccine Design I

Dennis R. Burton, The Scripps Research Institute, USA
Scripps CHAVD Vaccine Strategies

Barton F. Haynes, Duke University Medical Center, USA
Duke CHAVD Immunogen Design and Clinical Trials Results

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


THURSDAY, JUNE 8

07:00—08:00
Breakfast

08:00—11:00
Rational Vaccine and Adjuvant (Joint)

William Schief, The Scripps Research and IAVI, USA
Germline Targeting Strategies: mRNA EOD/Trimer Studies

Susan K. Pierce, NIAID, National Institutes of Health, USA
Affinity Thresholds and Fate Decisions in Memory B Cells

Coffee Break

Andrew B. Ward, The Scripps Research Institute, USA
HIV Structural Studies and implications for Vaccine Development

Galit Alter, Moderna, Inc., USA
Correlates of Antibody Immunity Against Infectious Diseases

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop 2

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Antigen Driven Activation, Selection and Metabolic Re-Programming

Pavel Tolar, University College London, UK
Regulation of antigen persistence in germinal centres

Gabriel D. Victora, Rockefeller University, USA
Evolution of Antibody Responses to Infection and Immunization

Jason G. Cyster, HHMI/University of California, San Francisco, USA
Cell Migration Dynamics and Intercellular Communications Underlying Immunity

Short Talks Chosen from Abstracts

17:00—19:00
Translational HIV Vaccine Research

Alejandro Balazs, Massachusetts General Hospital, USA
Antibody-mediated Prevention of Vaginal HIV Transmission is Dictated by IgG Subclass in Humanized Mice

Devin Sok, International AIDS Vaccine Initiative, USA
IAVI Vaccine and Passive Antibody Trials in Africa

Louis J. Picker, Oregon Health & Science University, USA
Understanding the “Control and Clear” Efficacy of RhCMV/SIV Vaccine Vectors

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


FRIDAY, JUNE 9

07:00—08:00
Breakfast

08:00—11:00
Affinity Based Selection and Fate Decisions: Long Lived Plasma Cells and Memory B Cells

Frances Eun-Hyung Lee, Emory University, USA
Talk Title to be Announced

Coffee Break

Tomohiro Kurosaki, Osaka University, Japan
Functional Fates of Memory B Cells

Short Talks Chosen from Abstracts

08:00—11:00
Broadly Neutralizing Antibodies and Passive Immunization Against HIV and SARS-CoV-2

Penny L. Moore, University of the Witwatersrand and National Institute for Communicable Diseases, South Africa
HIV B Cell Biology and Implications for Vaccine Development

Marit van Gils, Amsterdam UMC, Netherlands
Characterization and Application of Human bnabs to SARS-CoV-2

Coffee Break

Laura M. Walker, Adagio Therapeutics, USA
Virus-Specific Neutralizing Antibody Development

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
Activation and Redemption of the Autoreactive B Cell Repertoire in Autoimmune

Ignacio Sanz, Emory University, School of Medicine, USA
B Cells and their Effector Progeny in Autoimmune Disease

Christopher C. Goodnow, Garvan Institute of Medical Research, Australia
B Cell Self-Nonself Discrimination and Redemption

Jennifer L. Gommerman, University of Toronto, Canada
B Cells in MS

Short Talks Chosen from Abstracts

17:00—19:00
Next Generation PrEP

Helen Rees, University of the Witwatersrand, South Africa
Talk Title to be Announced

Sharon Hillier, University of Pittsburgh School of Medicine, USA
Dapivirine Ring

Moupali Das, Gilead Sciences, USA
Lenacapavir Ultra-Long Acting

S. Rahima Benhabbour, University of North Carolina, USA
Harnessing Innovative Engineering to Desing the Next Generation Long-Acting PrEP

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 3


SATURDAY, JUNE 10

07:00—08:00
Breakfast

08:00—11:00
The Impact of Infectious Disease and Inflammation on the B Cell Compartment

Carola G. Vinuesa, Francis Crick Institute, UK
Mechanisms Underpinning Human Systemic Autoimmunity: Lessons from Inborn Errors of Immunity

Marion Pepper, University of Washington, USA
B Cell Response in Malaria

Coffee Break

Facundo D. Batista, Massachusetts Institute of Technology and Harvard University, USA
Cell Metabolic Re-Programming

Short Talks Chosen from Abstracts

08:00—11:00
Update on HIV Vaccine Trials

Hanneke Schuitemaker, Janssen Vaccines & Prevention B.V., Netherlands
Ad26 Vaccines for COVID and HIV

Margaret Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HVTN Updates: Adjuvants and SOSIP Trimer Trials

Coffee Break

Hyman Scott, University of California, San Francisco, USA
Talk Title to be Announced

Glenda E. Gray, South African Medical Research Council, South Africa
Next Generation of Efficacy Studies; Vaccine Development in era of Long Acting PrEP

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 3

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—18:45
B Cell Malignancy Checkpoints and Targets of Therapies

Louis M. Staudt, NCI, National Institutes of Health, USA
Curing Lymphoma by Understanding B Cell Biology

Sandrine Roulland, Aix Marseille University, France
B Cell State Heterogeneity and Lymphomagenesis

Karin Tarte, INSERM U917 Université de Rennes 1, France
Follicular Lymphoma Microenvironment: Plasticity and Origin

Short Talks Chosen from Abstracts

17:00—18:45
Leveraging HIV Prevention Advances for the Cure Agenda

Julie Ake, Walter Reed Army Institute of Research, USA
Cure Approaches from NHP to Human

Marina F. Caskey, Rockefeller University, USA
bNabs-Eliciting Vaccine Strategies for HIV Cure

Steven G. Deeks, University of California, San Francisco, USA
Therapeutic Vaccination for HIV Cure

Short Talks Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.


SUNDAY, JUNE 11

08:00—08:00
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge additional support from these exhibitors at this conference:

BioLegend, Inc.
Please stop by to meet these exhibitors during the conference.


We gratefully acknowledge additional support for this conference from:

AdipoGen Life Sciences

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: John Monson, Director of Corporate Relations, Email: johnm@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179